Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $2.62 per share which beat the analyst consensus estimate of $1.75 by 49.71 percent. This is a 0.38 percent increase over earnings of $2.61 per share from the same period last year. The company reported quarterly sales of $651.000 million which beat the analyst consensus estimate of $623.989 million by 4.33 percent. This is a 0.09 percent decrease over sales of $651.600 million the same period last year.